Results 201 to 210 of about 31,184 (259)

Factors determining compliance with recommended intravitreal injections for retinal diseases among out-of-pocket, fully subsidized (non-paying), and insured patients: Real-world evidence from India. [PDF]

Indian J Ophthalmol
Das AV, Kashyap B, Takkar B, Venugopal R, Chatterjee C, Mehta MC, Stewart MW, Murthy GVS, Khanna RC, Das T, Narayanan R.   +10 more
europepmc   +1 more source

Intravitreal Injections of Cord Blood Platelet-Rich Plasma in Dry Age-Related Macular Degeneration: Regenerative Therapy. [PDF]

Ophthalmol Sci
Savastano MC, Fossataro C, Berni A, Savastano A, Cestrone V, Giannuzzi F, Boselli F, Carlà MM, Cusato M, Mottola F, Pirolo R, D'Agostino E, Biagini I, Marcelli S, Gravina A, Shen M, Rizzo C, Valentini CG, Bianchi M, Teofili L, Cheng Y, Wang RK, Rosenfeld PJ, Rizzo S.   +23 more
europepmc   +1 more source

Acceptance of the Disease in Patients Diagnosed with Neovascular Age-Related Macular Degeneration Depending on Visual Parameters-Before and After a Series of Seven Intravitreal Injections. [PDF]

J Clin Med
Nowak M, Cybulska AM, Schneider-Matyka D, Grochans E, Walaszek I, Panczyk M, Nowicki GJ, Rachubińska K.   +7 more
europepmc   +1 more source

Macular edema in Wyburn-Mason syndrome: Resolution with anti-VEGF intravitreal injections. Case report and review of the literature. [PDF]

Am J Ophthalmol Case Rep
Hupin N, Cahill T, Boschi A, Kozyreff A.
europepmc   +1 more source

Analysis of topical conjunctival microbiotic cultures in patients treated with intravitreal injections using antibiotic prophylaxis with 0.3% ofloxacin eye drops. [PDF]

Int J Retina Vitreous
de Miranda Gonçalves LB, Campos MLLS, Barros GF, da Veiga GL, Silva JA, Fonseca FLA, Gascón TM, de Carvalho SS, de Carvalho AKR, Fernandes GEP, Lima VL, Lima TM.   +11 more
europepmc   +1 more source

Efficacy and safety of intravitreal injections of conbercept for the treatment of idiopathic choroidal neovascularization. [PDF]

BMC Ophthalmol
Zhai G, Su Y, Wang S, Lu H, Liu N.
europepmc   +1 more source

The Effect of Glucagon-like-Peptide-1 Receptor Agonists on Diabetic Retinopathy Progression, Central Subfield Thickness, and Response to Intravitreal Injections. [PDF]

J Clin Med
Michaeli T, Khateb S, Levy J.
europepmc   +1 more source

Intravitreal injection technique.

Community eye health, 2015
openaire   +1 more source

Complications of intravitreal injections

Current Opinion in Ophthalmology, 2010
Over the past few years, the results of many studies have highlighted the risks and benefits of intravitreal injection of a number of medications, the most common being triamcinolone, antivascular endothelial growth factor (VEGF) agents, antibiotics, antivirals, antifungals, and methotrexate. The purpose of this review is to highlight the complications
Sampat, Kapil M., Garg, Sunir J.
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Endophthalmitis following intravitreal injections

Graefe's Archive for Clinical and Experimental Ophthalmology, 2011
To report the clinical features, culture results, management and visual outcome of patients with endophthalmitis following intravitreal injections.Retrospective review of all patients with suspected endophthalmitis after intravitreal injections treated with intravitreal antibiotics (teicoplanin and ciprofloxacin) at a referral centre between January ...
Theodor Stappler, Heinrich Heimann
exaly   +3 more sources